Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.
(Nature[JO] AND ("Novel Coronavirus" OR COVID-19 OR SARS-CoV-2 OR 2019-nCoV))
975 results
  • Behavioral Nudges Increase COVID-19 Vaccinations. [Journal Article]
    Nature. 2021 Aug 02 [Online ahead of print]Dai H, Saccardo S, … Croymans DM
  • Enhancing vaccine uptake is a critical public health challenge1. Overcoming vaccine hesitancy2,3 and failure to follow-through on vaccination intentions3 requires effective communication strategies3,4. We present two sequential randomized controlled trials (RCTs) to test the impact of behavioral interventions on COVID-19 vaccine uptake. We designed text-based reminders that make vaccination salie…
  • Rapid and stable mobilization of CD8+ T cells by SARS-CoV-2 mRNA vaccine. [Journal Article]
    Nature. 2021 Jul 28 [Online ahead of print]Oberhardt V, Luxenburger H, … Hofmann M
  • SARS-CoV-2 spike mRNA vaccines1-3 mediate protection from severe disease as early as 10 days post prime vaccination3, when neutralizing antibodies are hardly detectable4-6. Vaccine-induced CD8+ T cells may thus be the main mediators of protection at this early stage7,8. The details of their induction, comparison to natural infection, and association with other arms of vaccine-induced immunity rem…
  • A natively flexible 32-bit Arm microprocessor. [Journal Article]
    Nature. 2021 07; 595(7868):532-536.Biggs J, Myers J, … White S
  • Nearly 50 years ago, Intel created the world's first commercially produced microprocessor-the 4004 (ref. 1), a modest 4-bit CPU (central processing unit) with 2,300 transistors fabricated using 10 μm process technology in silicon and capable only of simple arithmetic calculations. Since this ground-breaking achievement, there has been continuous technological development with increasing sophistic…
  • Broad sarbecovirus neutralization by a human monoclonal antibody. [Journal Article]
    Nature. 2021 Jul 19 [Online ahead of print]Tortorici MA, Czudnochowski N, … Pizzuto MS
  • The recent emergence of SARS-CoV-2 variants of concern (VOC)1-10 and the recurrent spillovers of coronaviruses11,12 in the human population highlight the need for broadly neutralizing antibodies that are not affected by the ongoing antigenic drift and that can prevent or treat future zoonotic infections. Here, we describe a human monoclonal antibody (mAb), designated S2X259, recognizing a highly …
New Search Next